Date Filed | Type | Description |
08/01/2017 |
SC 13D/A
| European High-Tech Capital S.A. reports a 0% stake in Syneron Medical Ltd. |
07/27/2017 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
07/17/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/17/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/17/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/17/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/17/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/17/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
07/17/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
07/07/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
06/15/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
05/30/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
05/18/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
05/15/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
05/11/2017 |
SC 13D/A
| Sand Grove Capital Management LLP reports a 4.3% stake in SYNERON MEDICAL LTD |
05/10/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
05/10/2017 |
SC 13D
| Sand Grove Capital Management LLP reports a 5.2% stake in SYNERON MEDICAL LTD |
05/01/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
04/19/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
04/10/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
04/03/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
04/03/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
03/27/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
03/23/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
03/23/2017 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
03/20/2017 |
4
| NORTH TIDE CAPITAL, LLC (10% Owner) has filed a Form 4 on Syneron Medical Ltd.
Txns:
| Sold 81,500 shares
@ $10.275, valued at
$837.4k
Sold 34,000 shares
@ $10.3, valued at
$350.2k
|
|
03/08/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
02/15/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
02/14/2017 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in Syneron Medical Ltd. |
02/14/2017 |
SC 13G/A
| North Tide Capital Master, LP reports a 10.1% stake in SYNERON MEDICAL LTD. |
02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
01/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
01/06/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
11/09/2016 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
|